Facebook: UIC: USA Investing Club
WhatsApp: UIC: USA Investing Club
Telegram: UIC: USA Investing Club
-------------------------------------------------------------
In this comprehensive equity research report, we analyze:
✔ Eli Lilly's business model
✔ Mounjaro & Zepbound market opportunity
✔ Orforglipron (oral GLP-1) growth potential
✔ Retatrutide and future obesity treatments
✔ Oncology, neuroscience & Alzheimer's pipeline
✔ Financial performance and profitability trends
✔ Competitive comparison with Novo Nordisk, Pfizer and AstraZeneca
✔ Key investment risks and red flags
✔ Bull, Base and Bear valuation scenarios
✔ Long-term outlook through 2030
Can Eli Lilly become the first pharmaceutical company to sustainably generate $100B+ in annual revenue? This report explores the opportunities, risks, and investment thesis behind one of the market's most closely watched healthcare stocks.
📌 Company: Eli Lilly & Company (NYSE: LLY)
📌 Research Date: May 2026
📌 Presented by Dreamlit Quant Research
⚠️ Disclaimer:
This video is for educational and research purposes only and should not be considered financial, investment, legal, or tax advice. Always conduct your own research before making investment decisions.
UIC: USA Investing Club
Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from UIC: USA Investing Club, Education, Washington D.C., DC.
06/03/2026
The Most Important Healthcare Company of the Decade? Facebook: UIC: USA Investing ClubWhatsApp: UIC: USA Investing Clu...
Facebook: UIC: USA Investing Club
WhatsApp: UIC: USA Investing Club
Telegram: UIC: USA Investing Club
-------------------------------------------------------------
Topics covered in this video:
Key Metrics (Nebius Group N.V.)
One of tech's most complex corporate reinventions
What Nebius Inherited From Yandex
What is a Neocloud?
AI Cloud - GPU Rental
AI Studio - Inference Platform
Enterprise Dedicated Clusters
Sovereign AI & European Cloud
Section 3: Financial Analysis
Section 4: Strategic Partnerships & Contract Backlog
Section 5: Infrastructure Footprint & Hardware Strategy
Energy Strategy — The Hidden Moat
Section 6: Subsidiaries, Investments & Portfolio Companies (Nebius AI Cloud, Toloka AI, TripleTen, Avride, ClickHouse, Israeli National Supercomputer)
Section 7: Competitive Landscape (Nebius vs CoreWeave vs Hyperscalers)
Section 8: Red Flags & Investment Risks
Section 10: Price Projection — Bull / Base / Bear
Section 10B: Valuation Framework & Peer Comparison
What to track every quarter
Nebius Group — Summary View
One-line thesis
Why it's different
What we like
What worries us
Disclaimer: This is for education and entertainment only. Not financial advice. Do your own research.
05/26/2026
https://youtu.be/ZeoGtYxiveM?si=MKrE1osTW6uydt8p
The Best-Capitalized AI Neocloud You’ve Never Heard Of Facebook: UIC: USA Investing ClubWhatsApp: UIC: USA Investing ClubTelegram: UIC: USA Investing Club---------------------------------------------------------...
05/18/2026
# # The Mathematical Reality of Indian Capital in US Markets
Quantifying the exact US market return (USD) required to match a domestic Nifty 50 investment compounding at an annualized 12% rate after accounting for all frictional costs, currency movements, and tax brackets for an investor in the 30% slab.
# # # Model Benchmarks and Constraints
* **Currency Dynamics:** Baseline spot rate of ₹96.00/$ with a historical structural INR depreciation of 4.0% per annum.
* **Transaction Costs:** Forex spread of 0.8% per conversion leg, 18% GST applied to the forex fee, and a flat ₹1,180 bank wire charge per outward remittance.
* **Tax Framework:** US short-term capital gains (holding period under 2 years) taxed at a 31.2% effective rate (30% slab plus 4% cess). US long-term capital gains (holding period of 2 years or more) taxed at a 13.0% effective rate (12.5% plus 4% cess).
* **Tax Collection Upfront:** A 20% Tax Collected at Source (TCS) applies to remittances exceeding ₹10 Lakh per fiscal year, recoverable during income tax filing.
* **Domestic Alternative:** Nifty 50 benchmarked at a conservative 12.0% CAGR. Domestic short-term capital gains (under 1 year) are 20.8%, and long-term capital gains are 13.0% with a ₹1,25,000 annual exemption.
# # # Required US Market CAGR by Capital Class
* **Capital Outlay: ₹5 Lakh**
* 9-Month Holding Period: 13.99% US CAGR required.
* 12-Month Holding Period: 16.37% US CAGR required.
* 2-Year Holding Period: 10.60% US CAGR required.
* 5-Year Holding Period: 8.66% US CAGR required.
* **Capital Outlay: ₹10 Lakh**
* 9-Month Holding Period: 13.74% US CAGR required.
* 12-Month Holding Period: 16.18% US CAGR required.
* 2-Year Holding Period: 9.73% US CAGR required.
* 5-Year Holding Period: 8.40% US CAGR required.
* **Capital Outlay: ₹15 Lakh**
* 9-Month Holding Period: 14.66% US CAGR required.
* 12-Month Holding Period: 16.63% US CAGR required.
* 2-Year Holding Period: 9.84% US CAGR required.
* 5-Year Holding Period: 8.42% US CAGR required.
* **Capital Outlay: ₹20 Lakh**
* 9-Month Holding Period: 15.18% US CAGR required.
* 12-Month Holding Period: 16.82% US CAGR required.
* 2-Year Holding Period: 9.90% US CAGR required.
* 5-Year Holding Period: 8.43% US CAGR required.
* **Capital Outlay: ₹50 Lakh**
* 9-Month Holding Period: 16.21% US CAGR required.
* 12-Month Holding Period: 17.21% US CAGR required.
* 2-Year Holding Period: 10.02% US CAGR required.
* 5-Year Holding Period: 8.45% US CAGR required.
# # # Structural Conclusions
* **The 12-Month Tax Asymmetry Spike:** The required US hurdle rate reaches its maximum at the 12-month mark. At 1 year, domestic investments qualify for LTCG (13% tax with an exemption), while US equities remain trapped under STCG classification (31.2% tax) for 24 months.
* **TCS Cash Drag:** For capital exceeding ₹10 Lakh, the 20% upfront TCS lockup degrades short-term capital efficiency, forcing higher active returns at 9 and 12 months.
* **Currency Insulated Horizons:** For long-term holding periods (2 to 5 years), the 4.0% annualized depreciation of the rupee offsets entry frictions, lowering the required organic US market growth to the ~8.4%–10.6% range to maintain domestic parity.
05/06/2026
$AMD AMD Q1 FY26:
• Revenue +38% Y/Y to $10.3B ($0.3B beat).
• Operating margin 14% (+4pp Y/Y).
• Non-GAAP EPS $1.37 ($0.08 beat).
• Q2 FY26 rev guide ~$11.2B ($0.7B beat).
04/16/2026
🚀 sees margins pushing even higher in 2Q26, set to hit another record. Gross margin is guided at 65.5%–67.5%, driven by stronger fab utilization, continued cost optimization, and relentless AI demand.
04/16/2026
$ASML ASML Q1 FY26:
• Net sales +13% Y/Y to €8.8B (€0.1B beat).
• Gross margin 53% (-1pp Y/Y).
• Operating margin 36% (+1pp Y/Y).
• EPS €7.15 (€0.54 beat).
• FY26 Net sales ~€38B (€1.5B raise).
04/02/2026
Click here to claim your Sponsored Listing.
Location
Category
Website
Address
Washington D.C., DC